Sattler AM - Search Results

1

The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels.

Brönner G, Sattler AM, Hinney A, Soufi M, Geller F, Schäfer H, Maisch B, Hebebrand J, Schaefer JR. Brönner G, et al. Among authors: sattler am. J Clin Endocrinol Metab. 2006 Feb;91(2):535-8. doi: 10.1210/jc.2005-0919. Epub 2005 Nov 8. J Clin Endocrinol Metab. 2006. PMID: 16278267

2

Osteoprotegerin gene polymorphisms in men with coronary artery disease.

Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC, Schaefer JR. Soufi M, et al. Among authors: sattler am. J Clin Endocrinol Metab. 2004 Aug;89(8):3764-8. doi: 10.1210/jc.2003-032054. J Clin Endocrinol Metab. 2004. PMID: 15292302

3

Increased osteoprotegerin serum levels in men with coronary artery disease.

Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC. Schoppet M, et al. Among authors: sattler am. J Clin Endocrinol Metab. 2003 Mar;88(3):1024-8. doi: 10.1210/jc.2002-020775. J Clin Endocrinol Metab. 2003. PMID: 12629080

4

Mutation screening of the APOA5 gene in subjects with coronary artery disease.

Soufi M, Sattler AM, Kurt B, Schaefer JR. Soufi M, et al. Among authors: sattler am. J Investig Med. 2012 Oct;60(7):1015-9. doi: 10.2310/JIM.0b013e3182686918. J Investig Med. 2012. PMID: 22914599

5

Molecular mechanisms involved in atherosclerosis.

Soufi M, Sattler AM, Maisch B, Schaefer JR. Soufi M, et al. Among authors: sattler am. Herz. 2002 Nov;27(7):637-48. doi: 10.1007/s00059-002-2431-2. Herz. 2002. PMID: 12439635 Review.

6

Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.

Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK. Spiecker M, et al. Among authors: sattler am. Circulation. 2004 Oct 12;110(15):2132-6. doi: 10.1161/01.CIR.0000143832.91812.60. Epub 2004 Oct 4. Circulation. 2004. PMID: 15466638 Free PMC article.

7

Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.

Soufi M, Kurt B, Schweer H, Sattler AM, Klaus G, Zschocke J, Schaefer JR. Soufi M, et al. Among authors: sattler am. Atheroscler Suppl. 2009 Dec 29;10(5):5-11. doi: 10.1016/S1567-5688(09)71802-1. Atheroscler Suppl. 2009. PMID: 20129366

8

Strategies to optimize CAD prevention in modern cardiology. The "Marburg CAD Prevention Project".

Schaefer JR, Simon B, Soufi M, Sattler A, Noll B, Herzum M, Maisch B. Schaefer JR, et al. Herz. 2000 Mar;25(2):113-6. doi: 10.1007/pl00001948. Herz. 2000. PMID: 10829250 Clinical Trial.

9

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).

Schaefer JR, Kurt B, Sattler A, Klaus G, Soufi M. Schaefer JR, et al. Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):2-6. doi: 10.1007/s11789-012-0041-y. Clin Res Cardiol Suppl. 2012. PMID: 22528129 Free PMC article.

10

A new but frequent mutation of apoB-100-apoB His3543Tyr.

Soufi M, Sattler AM, Maerz W, Starke A, Herzum M, Maisch B, Schaefer JR. Soufi M, et al. Among authors: sattler am. Atherosclerosis. 2004 May;174(1):11-6. doi: 10.1016/j.atherosclerosis.2003.12.021. Atherosclerosis. 2004. PMID: 15135245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters